
Shirdi Pharmaceutical Consultancy Private Limited
Provides pharmaceutical consulting services since 2013, based in Bangalore.
Provides pharmaceutical consulting services since 2013, based in Bangalore.
Shirdi Pharmaceutical Consultancy Private Limited (SPCPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 May 2013 and has a history of 12 years. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Konasagara Thippeswamy, Ganesh Bhat, Yeraguntlu Eswaramma, and Four other members serve as directors at the Company.
Bangaluru, Karnataka, India
+91-XXXXXXXXXX
U85110KA2013PTC069267
069267
Private Limited Indian Non-Government Company
23 May 2013
30 Sep 2019
31 Mar 2019
Unlisted
Roc Bangalore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ganesh Bhat ![]() | Director | 23-May-2013 | Current |
Konasagara Thippeswamy ![]() | Director | 23-May-2013 | Current |
Yeraguntlu Eswaramma ![]() | Director | 13-Jan-2014 | Current |
Narasimha Murthy ![]() | Director | 11-Aug-2014 | Current |
Appanna Jayamma ![]() | Director | 11-Aug-2014 | Current |
Parwathamma ![]() | Director | 11-Aug-2014 | Current |
Shirdi Pharmaceutical Consultancy Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 97.72% decrease. The company also saw a substantial fall in profitability, with a 496.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.09%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Shirdi Pharmaceutical Consultancy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ganesh Bhat is a mutual person
Ganesh Bhat is a mutual person
Ganesh Bhat and Yeraguntlu Eswaramma are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shirdi Pharmaceutical Consultancy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shirdi Pharmaceutical Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shirdi Pharmaceutical Consultancy's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shirdi Pharmaceutical Consultancy Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Shirdi Pharmaceutical Consultancy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore.
Narasimha Geetha Murthy was appointed as a Director was appointed as a Director on 11 Aug 2014 & has been associated with this company since 10 years 9 months .
Appanna Jayamma was appointed as a Director was appointed as a Director on 11 Aug 2014 & has been associated with this company since 10 years 9 months .
Parwathamma was appointed as a Director was appointed as a Director on 11 Aug 2014 & has been associated with this company since 10 years 9 months .
Yeraguntlu Rudranna Eswaramma was appointed as a Director was appointed as a Director on 13 Jan 2014 & has been associated with this company since 11 years 4 months .
Shirdi Pharmaceutical Consultancy Private Limited was incorporated on 23 May 2013.
The authorized share capital of Shirdi Pharmaceutical Consultancy Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Currently 7 directors are associated with Shirdi Pharmaceutical Consultancy Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Shirdi Pharmaceutical Consultancy Private Limited is No651 Nalme13Thcrosschandralayout1Ststage, 1Stphase India, Bangalore, Karnataka, 560079.
The corporate identification number (CIN) of Shirdi Pharmaceutical Consultancy Private Limited is U85110KA2013PTC069267 and the company number is 069267 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2019, the revenue trend for Shirdi Pharmaceutical Consultancy Private Limited has fallen by -97.72%.
The financial reports for the fiscal year 2019 indicates that The net worth of Shirdi Pharmaceutical Consultancy Private Limited has experienced an downturn of -89.09%.
The most recent Balance Sheet for Shirdi Pharmaceutical Consultancy Private Limited was filed with the ROC on 31 Mar 2019.
Search company & director profiles for free and gain access to critical business data.
YS